Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- presença de fatores de risco
- ataques repetidos de dor unilateral
- curta duração
- dor excruciante
- lacrimejamento, rinorreia e síndrome de Horner parcial
- agitação e inquietação
Fatores de risco
- sexo masculino
- história familiar
- traumatismo cranioencefálico
- tabagismo
- consumo excessivo de álcool
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- RNM de cérebro e hipófise sem e com contraste intravenoso
- velocidade de hemossedimentação
Investigações a serem consideradas
- testes de função da hipófise
- angiografia por ressonância magnética (ARM) de cabeça e pescoço com e sem contraste
- tomografia computadorizada (TC) cranioencefálica
- polissonografia
- eletrocardiograma (ECG)
Algoritmo de tratamento
ataque agudo: sem doença cardiovascular, doença cerebrovascular ou hipertensão não controlada
ataque agudo: com doença cardiovascular, doença cerebrovascular ou hipertensão não controlada
tratamento preventivo para cefaleia em salvas episódica
tratamento preventivo para cefaleia em salvas crônica
Colaboradores
Autores
Juliana VanderPluym, MD, FRCPC, FAHS
Associate Professor of Neurology
Department of Neurology
Mayo Clinic Arizona
Scottsdale
AZ
Declarações
JVP has received a research grant from Amgen. She has previously acted as a consultant for Teva and is on the editorial board of the American Migraine Foundation. JVP is a co-editor of the Headache section for Current Neurology and Neuroscience Reports.
Amaal J. Starling, MD
Associate Professor of Neurology
Department of Neurology
Mayo Clinic Arizona
Scottsdale
AZ
Declarações
AJS serves on the Board of Directors for the American Headache Society, the Alliance for Headache Disorders Advocacy, and the United Council for Neurologic Subspecialties. AJS has received consulting fees from AbbVie, Allergan, Amgen, Axsome Therapeutics, Eli Lilly & Company, Everyday Health, Impel, Lundbeck, Med-IQ, Medscape, Neurolief, Novartis, Satsuma, Teva, and Theranica. None are directly related to the topic of cluster headache.
Christoper C. Anderson, MD
Headache Medicine Fellow Physician
Mayo Clinic Arizona
Scottsdale
AZ
Declarações
CCA declares that he has no competing interests.
Agradecimentos
Dr Juliana VanderPluym, Dr Amaal J. Starling, and Dr Christopher C. Anderson would like to gratefully acknowledge Dr Sarah Miller, Dr Alok Tyagi, Dr Manjit S. Matharu, Dr Marc S. Husid, and Dr Davis L. Mellick, previous contributors to this topic.
Declarações
SM received an educational grant from St Jude Medical and Medtronic, and received payment for educational presentations from Allergan and Autonomic Technologies, Inc. AT was on advisory boards for Allergan and electroCore, and received organisational payments from eNeura, Allergan, and electroCore. MSM served on the advisory board for Allergan, St Jude Medical, and Medtronic, and received payment for the development of educational presentations from Allergan, MSD, Medtronic, and electroCore. MSH and DLM declare that they have no competing interests.
Revisores
Mark W. Green, MD, FAAN
Director of Headache and Pain Medicine
Professor of Neurology, Anesthesiology, and Rehabilitation Medicine
Icahn School of Medicine at Mount Sinai
New York
NY
Declarações
MWG declares that he has no competing interests.
Anne Walling, MD
Professor
Family and Community Medicine
University of Kansas School of Medicine
Wichita
KS
Declarações
AW declares that she has no competing interests.
Christian Lampl, MD, PhD
Department Head
Department of Neurology and Pain Medicine
Konventhospital Barmherzige Brüder Linz
Linz
Austria
Declarações
CL declares that he has no competing interests.
Referências
Principais artigos
Schindler EAD, Burish MJ. Recent advances in the diagnosis and management of cluster headache. BMJ. 2022 Mar 16;376:e059577. Resumo
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211.Texto completo Resumo
American College of Radiology. ACR appropriateness criteria: headache. 2022 [internet publication].Texto completo
Robbins MS, Starling AJ, Pringsheim TM, et al. Treatment of cluster headache: the American Headache Society evidence-based guidelines. Headache. 2016 Jul;56(7):1093-106.Texto completo Resumo
Law S, Derry S, Moore RA. Triptans for acute cluster headache. Cochrane Database Syst Rev. 2013 Jul 17;(7):CD008042.Texto completo Resumo
May A, Evers S, Goadsby PJ, et al. European Academy of Neurology guidelines on the treatment of cluster headache. Eur J Neurol. 2023 Oct;30(10):2955-79.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Enxaqueca
- Hemicrania paroxística
- Ataques de cefaleia de curta duração, unilateral, neuralgiforme com hiperemia conjuntival e lacrimejamento (SUNCT)
Mais Diagnósticos diferenciaisDiretrizes
- European Academy of Neurology guidelines on the treatment of cluster headache
- Headaches in pregnancy and postpartum: ACOG clinical practice guideline no. 3
Mais DiretrizesFolhetos informativos para os pacientes
Cefaleia em salvas: o que é?
Cefaleia em salvas: quais tratamentos estão disponíveis?
Mais Folhetos informativos para os pacientesConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal